Skip to content

Role of jujube oxymel treatment in patients withchronic idiopathic urticaria

Role of jujube oxymel treatment in patients withchronic idiopathic urticaria

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190304042916N1
Enrollment
90
Registered
2019-04-30
Start date
2019-08-23
Completion date
Unknown
Last updated
2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic idiopathic urticaria. Idiopathic urticaria

Interventions

Intervention group: Snake Jaban Syrup for three monthsTo 40 patients once a day and 10 cc.

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: These patients should be equal or over the age of 18 years to 70 years of age,At least 6 weeks have suffered from symptoms Do not get pregnant There is no history of autoimmune disease or immunodeficiency There is no previous sensitivity to antihistaminic drugs There is no previous sensitivity to any of the ingredients in the herbal medicinal product (sycamore). Willing to participate in the study

Exclusion criteria

Exclusion criteria: Age under 18 and over 70 years There are symptoms of hives less than 6 weeks Pregnant or breastfeeding There is a history of autoimmune disease or immunodeficiency History of hypersensitivity to antihistamines History of herbivorous sensation Unwillingness to participate in the study

Design outcomes

Primary

MeasureTime frame
Reduced drug intake during the course of treatment. Timepoint: From the first week to the twelfth week. Method of measurement: Number of pills (citrine, meloxate, ranitidine and prednisolone) consumed by the patient.

Secondary

MeasureTime frame
Score obtained from the questionnaire chronic utcaria quality of life. Timepoint: The first turn is the start of the study-The second turn is the sixth week of treatment-Third turn of the twelfth week of treatment. Method of measurement: The score of the standard questionnaire.;Scores obtained from the questionnaire Urticarial sevrity score. Timepoint: The first turn is the start of the study-The second turn is the sixth week of treatment-Third turn of the twelfth week of treatment. Method of measurement: The score of the standard questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public Contacthamid zare

Shiraz University of Medical Sciences

hzare@sums.ac.ir+98 71 3212 7323

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 8, 2026